Literature DB >> 12105151

Cyclooxygenase-2 inhibition and cardiovascular events.

Bertram Pitt, Carl Pepine, James T Willerson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12105151     DOI: 10.1161/01.cir.0000025261.58465.62

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  14 in total

Review 1.  An evidence-based update on nonsteroidal anti-inflammatory drugs.

Authors:  C K S Ong; P Lirk; C H Tan; R A Seymour
Journal:  Clin Med Res       Date:  2007-03

2.  Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.

Authors:  Stephen P Motsko; Karen L Rascati; Anthony J Busti; James P Wilson; Jamie C Barner; Kenneth A Lawson; Jason Worchel
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Antiplatelet therapy from clinical trials to clinical practice.

Authors:  Shereif H Rezkalla; Michele Benz
Journal:  Clin Med Res       Date:  2003-04

Review 4.  Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.

Authors:  Anne Henrieke Tavenier; Renicus Suffridus Hermanides; Jan Paul Ottervanger; Peter Gerrit Johannes Ter Horst; Elvin Kedhi; Adriaan W J van 't Hof
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

5.  The role of cyclo-oxygenase-1 in high-salt diet-induced microvascular dysfunction in humans.

Authors:  Ana Cavka; Anita Cosic; Ivana Jukic; Bojan Jelakovic; Julian H Lombard; Shane A Phillips; Vatroslav Seric; Ivan Mihaljevic; Ines Drenjancevic
Journal:  J Physiol       Date:  2015-12-07       Impact factor: 5.182

6.  Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.

Authors:  Jian-Yong Qian; Pamela Harding; Yunhe Liu; Ed Shesely; Xiao-Ping Yang; Margot C LaPointe
Journal:  Hypertension       Date:  2008-01-07       Impact factor: 10.190

Review 7.  Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.

Authors:  Brent Caldwell; Sarah Aldington; Mark Weatherall; Philippa Shirtcliffe; Richard Beasley
Journal:  J R Soc Med       Date:  2006-03       Impact factor: 18.000

8.  Tissue factor, blood coagulation, and beyond: an overview.

Authors:  Arthur J Chu
Journal:  Int J Inflam       Date:  2011-09-20

9.  Selective cyclooxygenase-2 inhibition protects against myocardial damage in experimental acute ischemia.

Authors:  Alberto Carnieto; Paulo Magno Martins Dourado; Protásio Lemos da Luz; Antonio Carlos Palandri Chagas
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Acute coronary disease Athero-Inflammation: Therapeutic approach.

Authors:  Raul Altman
Journal:  Thromb J       Date:  2003-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.